Body weight could be a potentially confounding factor in assessment of circulating ghrelin levels, since OVX rats with vehicle treatment, and no estradiol replacement, were significantly heavier than intact females at the time of plasma collection, and obesity is associated with reduced ghrelin levels (19). The gene discussed is GHRL; the disease is obesity disorder.